On the Leading Edge of Radiation Research and Clinical Care

An integral part of cancer treatment since its discovery in 1896, advances in research and clinical techniques have dramatically increased the efficacy and precision of radiation therapy.

The Fred Hutch Radiation Oncology Division works at the intersection of research and clinical care to continuously harness the discoveries of radiation oncology scientists to treat patients across the care continuum.

Combining Research and Care

Over 50 faculty members, including physicians, medical physicists, researchers and instructors, have joint appointments in the Fred Hutch Radiation Oncology Division and UW Medicine Department of Radiation Oncology. 

They are working to leverage incredible advances in research and clinical techniques into world-class care for our patients.

Research Pillars

The Fred Hutch Radiation Oncology Division focuses on a number of research initiatives, including:

  • FLASH: FLASH radiotherapy is a technique that delivers ultra-high dose-rate radiation therapy, helping to improve patient outcomes by minimizing the damage to healthy tissues
  • Radiation immune modulation: Researching how immune responses to radiation therapy can help develop systemic antitumor immunity
  • Theranostics: By combining diagnostics and therapeutics, theranostics deliver precision radiation treatment that can dramatically reduce the damage to healthy tissues during treatment
  • Adaptive radiotherapy: By improving imaging and diagnostic techniques, radiotherapy treatments can be adapted for individual patients over the course of their treatment to improve safety and efficacy
  • AI and clinical informatics: Harnessing the potential of AI can improve processes and outcomes, and provide greater understanding across multiple fields of research
  • Health services and symptom science: Essential research into disease prevention, types of care delivery, survivorship and quality of care leads to better outcomes for patients while reducing health care disparities across populations
  • Global oncology: By promoting cancer care and research across the world, outcomes can be improved for patients regardless of their location

Proton Therapy

The one-of-a-kind cyclotron at the University of Washington gives us the ability to create radioisotopes, a groundbreaking form of radiation therapy.

UW Medical Cyclotron Facility

The one-of-a-kind cyclotron at the University of Washington gives us the ability to create radioisotopes, a groundbreaking form of radiation therapy.

Mian Lab

Omar Mian, MD, PhD, leads a team of researchers studying the molecular mechanisms underlying prostate and bladder cancers, with the goal of turning their findings into more effective treatments.

Latest Radiation Oncology Division News

All Radiation Oncology Division News
Fred Hutch researchers test privacy-first AI platform for cancer research After a year of building the infrastructure for its federated learning platform, the Cancer AI Alliance (CAIA) is road-testing eight projects using de-identified clinical data from four comprehensive cancer centers March 4, 2026
Kuni Foundation awards $7M to drive adult oncology research forward Vancouver, Washington-based foundation supports innovative early-stage research on new potential therapies June 30, 2025
50 years of doing hard things Founded in 1975 to honor a brother, Fred Hutch Cancer Center pursued bold science, pioneered a cure for blood diseases that changed medicine and became a world-class biomedical research and clinical care institution January 9, 2025
Outstanding people are the Heart of the Hutch Fred Hutch clinical and admin teams share their passion for helping patients, faculty July 16, 2024